[1] Darby S,Mcgale P,Correa C,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet,2011,378:1707-1716.
[2] Clarke M,Collins R,Darby S,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet,2005,366:2087-2106.
[3] van der Hage JA,van de Velde CJ,Julien J P,et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902[J]. J Clin Oncol,2001,19:4224-4237.
[4] Kuerer HM,Newman LA,Smith TL,et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy[J]. J Clin Oncol,1999,17:460-469.
[5] Bear HD,Anderson S,Smith RE,et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27[J]. J Clin Oncol,2006,24:2019-2027.
[6] Dominici LS,Negron GV,Buzdar AU,et al. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer[J]. Cancer,2010,116:2884-2889.
[7] Buchholz TA,Tucker SL,Masullo L,et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation[J]. J Clin Oncol,2002,20:17-23.
[8] Hoffman KE,Mittendorf EA,Buchholz TA. Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy[J]. Lancet Oncol,2012,13:270-276.
[9] Huang EH,Tucker SL,Strom EA,et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy,mastectomy,and radiotherapy[J]. Int J Radiat Oncol Biol Phys,2005,62:351-357.
[10] Mamounas EP,Anderson SJ,Dignam JJ,et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of national surgical adjuvant breast and bowel project B-18 and B-27[J]. J Clin Oncol,2012,30:3960-3966.
[11] Taghian A,Jeong JH,Mamounas E,et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials[J]. J Clin Oncol,2004,22:4247-4254.
[12] Nielsen HM,Overgaard M,Grau C,et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish breast cancer cooperative group DBCG 82 b and c randomized studies[J]. J Clin Oncol,2006,24:2268-2275.
[13] Daveau C,Stevens D,Brain E,et al. Is regional lymph node irradiation necessary in stage Ⅱ to Ⅲ breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?[J]. Int J Radiat Oncol Biol Phys,2010,78:337-342.
[14] Smith BD. Using chemotherapy response to personalize choices regarding locoregional therapy: a new era in breast cancer treatment?[J]. J Clin Oncol,2012,30:3913-3915.
[15] Bellon JR,Wong JS,Burstein HJ. Should response to preoperative chemotherapy affect radiotherapy recommendations after mastectomy for stage Ⅱ breast cancer?[J]. J Clin Oncol,2012,30:3916-3920.
[16] Le Scodan R,Selz J,Stevens D,et al. Radiotherapy for stage Ⅱ and stage Ⅲ breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy[J]. Int J Radiat Oncol Biol Phys,2012,82:1-7.
[17] de la Rochefordiere A,Asselain B,Campana F,et al. Age as prognostic factor in premenopausal breast carcinoma[J]. Lancet,1993,341:1039-1043.
[18] Nixon A J,Neuberg D,Hayes DF,et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage Ⅰ or Ⅱ breast cancer[J]. J Clin Oncol,1994,12:888-894.
[19] Agrup M,Stal O,Olsen K,et al. C-erbB-2 overexpression and survival in early onset breast cancer[J]. Breast Cancer Res Treat,2000,63:23-29.
[20] Garg AK,Oh JL,Oswald MJ,et al. Effect of postmastectomy radiotherapy in patients<35 years old with stage Ⅱ-Ⅲ breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy[J]. Int J Radiat Oncol Biol Phys,2007,69:1478-1483.
[21] Garg AK,Strom EA,Mcneese MD,et al. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage Ⅱ breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy[J]. Int J Radiat Oncol Biol Phys,2004,59:138-145.
[22] Settle SH,Gonzalez-Angulo AM,Buchholz TA,et al. Locoregional outcomes and radiotherapy response in patients with triple-negative breast cancer[J]. Int J Radiat Oncol Biol Phys,2009,75:9-10.
[23] Fowble BL,Einck JP,Kim DN,et al. Role of postmastectomy radiation after neoadjuvant chemotherapy in stage Ⅱ-Ⅲ breast cancer[J]. Int J Radiat Oncol Biol Phys,2012,83:494-503.
[24] Krishnamurthy S,Sneige N,Bedi DG,et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma[J]. Cancer,2002,95:982-988.
[25] Podkrajsek M,Music MM,Kadivec M,et al. Role of ultrasound in the preoperative staging of patients with breast cancer[J]. Eur Radiol,2005,15:1044-1050.
[26] Nagar H,Mittendorf EA,Strom EA,et al. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer[J]. Int J Radiat Oncol Biol Phys,2011,81:782-787.
[27] Huang EH,Strom EA,Perkins GH,et al. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score[J]. Int J Radiat Oncol Biol Phys,2006,66:352-357.
[28] Zhang YJ,Oh JL,Whitman GJ,et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control[J]. Int J Radiat Oncol Biol Phys,2010,77:1113-1119. |
|
|
2014, Vol. 23 
